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What's New: The effect of an outbreak of a novel infectious disease on parents' general
vaccine attitudes about childhood vaccines is unknown. We found that the onset of the
SARS-CoV-2 pandemic had a positive, albeit fleeting, effect on parent general vaccine
attitudes.

Abstract
Objective: To understand the influence of a novel infectious disease epidemic on parent
general attitudes about childhood vaccines.
Methods: We conducted a natural experiment utilizing cross-sectional survey data from
parents of infants in Washington and Colorado participating in a larger trial that began on
September 27, 2019. At enrollment, parents completed the short version of the Parental
Attitudes about Childhood Vaccines (PACV-SF), a validated survey scored from 0-4, with
higher scores representing more negative attitudes. The exposure variable was onset of the
SARS-CoV-2 pandemic in the US, with the before-period defined as September 27, 2019 ––
February 28, 2020 and the after-period defined as April 1, 2020 ––December 10, 2020, with
the after-period further separated into proximate (April 1, 2020-July 31, 2020) and distant
periods (August 1, 2020-December 10, 2020). The outcome variable was parent negative
attitudes about childhood vaccines, defined as a score of ≥2 on the PACV-SF. We estimated
the probability of the outcome after (vs. before) the exposure using log-binomial regression
with generalized estimating equations adjusted for demographic confounding variables.
Results: Among 4,562 parents, the risk of negative attitudes was lower immediately after (vs.
before) SARS-CoV-2 onset (adjusted risk ratio [aRR]: 0.58; 95% confidence interval [CI]:
0.36, 0.94; P=0.027), but by August–December 2020, the average rate of negative attitudes
was 35% higher than during April–July 2020 (aRR: 1.35; 95% CI: 1.13, 1.61; P=0.0009).
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Conclusions: A reduced risk of negative general vaccine attitudes observed immediately after
SARS-CoV-2 onset was quickly attenuated.

Introduction
Perceptions of one's susceptibility to and likelihood of illness from an infectious
disease are strongly correlated with the acceptance of an available vaccine to protect against
that infectious disease.1 However, data to support an association between an outbreak of
vaccine-preventable disease (VPD)––an event that could influence perceived illness
likelihood or susceptibility––and increased uptake of its corresponding vaccine has so far
been inconclusive.2-5 Moreover, few studies have examined the effect of an outbreak of a
specific VPD on attitudes and beliefs towards vaccines in general6,7 and no studies have
examined the effect of an emerging infectious disease on general vaccine attitudes and beliefs
prior to the availability of a vaccine for that infectious disease.
Addressing these gaps in our understanding of how infectious disease incidence
influences specific or general vaccine attitudes and behavior could help inform public health
interventions. For instance, when a vaccine against a specific infectious disease is available,
there is a need to increase uptake of this vaccine when the disease reaches epidemic
thresholds to curb further transmission and prevent further morbidity and mortality. When
there is not a vaccine yet available against a surging novel infectious disease, there is still
often a need to maintain or increase uptake of available vaccines against other infectious
diseases to prevent dual epidemics. This has been particularly salient during the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, during which childhood
vaccination rates in the United States have declined and threatened to spur additional
outbreaks of VPD.8-10 Our aim was to evaluate the effect of the SARS-CoV-2 pandemic prior
to the availability of a SARS-CoV-2 vaccine on parents' general attitudes about childhood
5

vaccines. We hypothesized that parent negative attitudes about childhood vaccines would be
lower after, as compared to before, the start of the pandemic.

Methods
We conducted a natural experiment using cross-sectional survey data collected from
parents enrolled in an ongoing cluster randomized controlled trial designed to assess the
effect of a novel, multifaceted clinician vaccine communication intervention on child
immunization status by study completion in 2023.11 The trial includes 24 primary care
pediatric clinics in Washington and Colorado (13 urban, 6 suburban, 1 rural, and 4 with
multiple geographic settings given that these clinics had more than one site) and began
enrolling parent participants on September 27, 2019. The study activities for this trial were
formally reviewed and approved by the Colorado Multiple Institutional Review Board,
Washington State Institutional Review Board, and Swedish Health Services Institutional
Review Board.

Data Collection
English- and Spanish-speaking parents ≥18 years old with an infant ≤2 months old
receiving health supervision at a clinic enrolled in the trial were eligible to participate. At
parent enrollment in the trial and prior to receipt of the study's intervention, all parents
completed the self-administered short version of the Parental Attitudes about Childhood
Vaccines (PACV), a validated survey based on Health Belief Model concepts, available in
multiple languages 12-15 and predictive of vaccine behavior.16-19 The short version of the
PACV (abbreviated as PACV-4 or PACV-SF) included 4 questions and was scored from 0-4,
with higher scores representing more negative attitudes and beliefs about childhood vaccines
(Table 1).20
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The content and order of questions on the PACV-SF survey did not change over the
study period. Given the prioritization of in-person visits for children <2 years old during the
pandemic, the mode of implementation of the survey (in-person, self-administered) also did
not change during the study period. Parent participants completed the PACV-SF only once.
The PACV-SF was embedded in a larger survey of items regarding parent attitudes about
non-vaccine-related care, such as breastfeeding and sleep (e.g., "It is important to introduce a
feeding schedule for my baby as early as possible," with response categories of strongly
agree, agree, not sure, disagree, and strongly disagree).
The PACV-SF also included demographics questions. Race and ethnicity was selfreported by parent participants, with race (American Indian or Alaska Native, Asian, Black or
African American, Native Hawaiian or Other Pacific Islander, and White) and ethnicity
(Hispanic or Latino) categories defined by investigators based on the US Office of
Management and Budget Standards. Reporting race and ethnicity in this study was mandated
by the US National Institutes of Health. We chose response categories for other demographic
questions based on those we utilized in past immunization studies,20 including the parents'
relationship to the enrolled child (mother, father, or other), whether the enrolled child was the
first-born (yes/no), parent age (18-29 years old, ≥30 years old), parents' current marital status
(divorced, separated, single, married, living with a partner, or widowed), parents' highest
level of education completed (8th grade or less, some high school but not a graduate, high
school graduate or GED, some college or 2 year degree, 4-year college degree, more than 4year college degree), approximate household income ($30,000 or less, $30,001-50,000,
$50,001-75,000, or $75,001 or more), and how many children in the household (1, 2, 3, or 4
or more).
The PACV-SF was included in the clinic's standard materials distributed to all parents
at check-in for that particular age visit. The survey was distinguished, however, with separate
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instructions to ensure parents were informed that its completion was voluntary and for
research purposes. We considered completed surveys to be documentation of consent. We did
not offer incentives to complete the survey, and we did not consistently collect declinations
or blank returned surveys to be able to determine response rates.

Exposure Variable
The exposure variable was the US onset of the SARS-CoV-2 pandemic. We considered the
pandemic's onset in the US to be the entire month of March 2020 to account for the World
Health Organization's declaration of the SARS-CoV-2 outbreak as a pandemic on March 11,
2020 and the dynamic nature of SARS-CoV-2 transmission in the US during March.21
Therefore, we excluded data obtained during March 2020 from our analyses. We defined the
time period before the start of the pandemic as September 27, 2019 (the start of parent
enrollment in the larger study) through February 28, 2020. We defined the time-period after
the start of the pandemic as April 1, 2020 through December 10, 2020. We excluded parent
PACV-SF data after December 10, 2020 to avoid contamination of parent general vaccine
attitudes by the availability of a vaccine against SARS-CoV-2 (the first SARS-CoV-2 vaccine
was granted an emergency use authorization by the US Food and Drug Administration on
December 11, 2020).

Outcome Variables
The primary outcome variable was the proportion of parents with negative attitudes about
childhood vaccines, with negative attitudes about childhood vaccines defined as a score of ≥2
on the PACV-SF, consistent with previous studies.20 Since an assumption in our natural
experiment was that the probability of parents holding negative attitudes about childhood
vaccines would have remained unchanged had the pandemic not occurred, we also utilized a
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secondary outcome variable that was not expected to change with the onset of the pandemic.
This secondary outcome variable was the proportion of parents who disagreed (defined as a
parent response of strongly disagree or disagree) to a non-vaccine-related attitudinal survey
item ("It is important to introduce a feeding schedule for my baby as early as possible").

Analysis
We used log-binomial regression with generalized estimating equations (GEE) to estimate the
probability of parent negative vaccine attitudes before and after the onset of the SARS-CoV-2
pandemic. GEE was used to account for clustering at the clinic level, and because our
outcome was collected prospectively and not rare (π > 0.05), log-binomial regression was
used to generate more interpretable risk ratio estimates.22 We included a linear term for time
in our models corresponding to the week in which parent attitudes about childhood vaccines
were sampled, a term for onset of the SARS-CoV-2 pandemic, and the interaction term
between pandemic onset and time. This parameterization allowed for both a slope and level
change in probability of having negative vaccine attitudes with respect to time, with a
potential discontinuity point at the onset of the pandemic. The fitted model therefore followed
the form
log 𝑃(𝑌𝑖𝑗 = 1) = 𝛽0 + 𝛽1 𝑇𝑖𝑗 + 𝛽2 𝑋𝑖𝑗 + 𝛽3 (𝑇𝑖𝑗 − 𝑇0 )𝑋𝑖𝑗
with 𝑌𝑖𝑗 the response value for the 𝑗th parent in the 𝑖th clinic, 𝑇𝑖𝑗 the time in study weeks that
this parent responded to the survey, 𝑇0 the time in study weeks at which the pandemic was
assumed to have begun, and 𝑋𝑖𝑗 equal to 1 if this survey was obtained during the pandemic
and 0 if obtained prior to the pandemic. The exponentiated regression coefficient for the
binary variable for onset of the pandemic is therefore the estimated risk ratio for negative
vaccine attitudes associated with the transition from pre-pandemic to pandemic time periods.
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To determine which covariates to adjust for in final models, we used GEE regression
as described above to test the association (1) between parent demographic characteristics and
negative vaccine attitudes and (2) between these same parent characteristics and the onset of
the pandemic. Those characteristics with p<0.2 in both univariate analyses were retained for
the final multivariable GEE model; these covariates were parent relationship to child, marital
status, and ethnicity. We used a similar approach to develop a multivariable log-binomial
GEE model for parent responses to the comparison non-vaccine related attitudinal survey
item before and after the onset of the SARS-CoV-2 pandemic. The final multivariable GEE
model used to assess the independent association between the onset of the pandemic and
parents disagreeing with the comparison survey item included parent relationship to child and
ethnicity as covariates.
We also conducted a secondary analysis of negative vaccine attitudes across 3
pandemic time periods. For this analysis, we characterized the SARS-CoV-2 pandemic using
a 3-level variable corresponding to 3 pandemic periods: pre-pandemic (September 27, 2019February 28, 2020), post-onset proximate period (April 1, 2020-July 31, 2020), and postonset distant period (August 1, 2020-December 10, 2020). Data from March 2020, considered
to be the onset of the SARS-CoV-2 pandemic in the US, was again excluded. We chose the
July 31, 2020 date as the boundary between post-onset proximate and distant periods because
it represented the approximate temporal mid-point of the post-onset period. We utilized logbinomial regression with GEE including a three-level variable for pandemic status (pre, postonset proximate, and post-onset distant). This parameterization allows for the estimation of
the average rate of parent negative vaccine attitudes across each pandemic time period. We
included demographic variables that were individually associated with both negative vaccine
attitudes and the onset of the pandemic at a significance level of <0.2 in a multivariable log-
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binomial GEE model (parent relationship to child, marital status, and ethnicity). We repeated
this analysis using the comparison non-vaccine related attitudinal survey item.
Lastly, we conducted a sensitivity analysis in which we utilized a more restrictive
definition for our primary outcome variable of negative parental attitudes about childhood
vaccines (a PACV-SF score of ≥3). A score of ≥2 out of 4 on the PACV-SF had high
specificity (79-81%) for identifying parents who scored ≥50 (out of 100) on the full 15-item
PACV––the score threshold significantly associated with an increase in under-immunization
of their child––when using previous PACV validation datasets.16,17 However, this PACV-SF
score threshold could result in up to 21% of parents being false positives (i.e. would not score
≥50 on the full PACV). At the more restrictive PACV-SF score threshold of ≥3 for negative
vaccine attitudes, the lower-limit specificity of the PACV-SF improved to 95%, making
misclassification of parents on the full PACV less likely. Using this more restrictive
definition, we performed log-binomial regression with GEE that included a linear term for
time, a term for onset of the SARS-CoV-2 pandemic, and the interaction between pandemic
onset and time. Second, we performed multivariable log-binomial regression with GEE that
included demographic variables associated with both negative vaccine attitudes and beliefs
and the onset of the pandemic at a significance level of <0.2 in univariate analyses (parent
marital status).

Results
There were 4,562 parent participants included in analysis (Table 2). Most were
mothers, married, ≥30 years old, and white. Parent participants who completed the PACV-SF
after the onset of the SARS-CoV-2 pandemic differed significantly by marital status,
ethnicity, and their relationship to the child compared to those who completed the PACV-SF
before pandemic onset.
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The risk that a parent had negative vaccine attitudes was lower immediately after (vs.
before) the onset of the pandemic (risk ratio [RR] associated with the pandemic onset term:
0.57; 95% Confidence Interval [CI]: 0.36, 0.91; P=0.019). There was no significant
difference observed in the probability of parents disagreeing with the non-vaccine-related
attitudinal item immediately after (vs. before) the onset of the SARS-CoV-2 pandemic (RR
1.03; 95% CI: 0.92, 1.15; P=0.591). In multivariable models adjusted for confounding by
demographic characteristics, we found no change in either the magnitude or significance of
the effect estimated in our unadjusted models: the risk that a parent participant had negative
vaccine attitudes remained lower immediately after (vs. before) the onset of the pandemic
(adjusted risk ratio [aRR]: 0.58; 95% CI: 0.36, 0.94; P=0.027), and the estimated risk that a
parent participant disagreed with the non-vaccine-related attitudinal item remained was not
significantly different immediately after (vs. before) the onset of the pandemic (aRR 1.04;
95% CI: 0.93, 1.16; P= 0.519).
In our secondary analysis, we found that the average rate of parent negative attitudes
about childhood vaccines was significantly higher pre-pandemic than during the post-onset
proximate period (aRR: 1.46; 95% CI: 1.23, 1.74; P<0.0001). However, we also found that
the reduced rate of negative vaccine attitudes in the post-onset proximate period was quickly
attenuated: the rate of negative vaccine attitudes was significantly higher in the post-onset
distant (vs. proximate) period (aRR: 1.35; 95% CI: 1.13, 1.61; P=0.0009) and there was no
significant difference in the average rate of negative vaccine attitudes between the post-onset
distant period and the pre-pandemic period (aRR: 1.09; 95% CI: 0.93, 1.27; P=0.30) (Figure
1a). By contrast, there were no significant difference observed in the average rate of parents
disagreeing with the non-vaccine attitudinal item across these three time periods (Figure 1b).
In our sensitivity analyses, we found results similar to our main analyses. The risk that
a parent had negative vaccine attitudes, defined as a PACV-SF score of ≥3, was significantly
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lower immediately after (vs. before) the onset of the pandemic (RR 0.45; 95% CI: 0.23, 0.88;
P=0.019). We observed the same effect in multivariable GEE log-binomial modeling (aRR
0.43; 95% CI: 0.21, 0.88; P=0.020).

Discussion
We found the risk that parents had negative general attitudes about childhood
vaccines was significantly lower immediately after (vs. before) the onset of the SARS-CoV-2
pandemic, but this effect dissipated by December 2020. Our study therefore provides
evidence for two important phenomena. First, our findings support the hypothesis that a
highly visible increase in the incidence of an infectious disease at a time when a vaccine to
prevent illness caused by that infectious disease is not yet available may positively influence
parents' general attitudes about childhood vaccines. To our knowledge, this is the first
evidence of this effect, though others have shown that parents' general attitudes about
childhood vaccines can improve after an increase in the incidence of an infectious disease in
which a vaccine is already available.6,7 Our results, therefore, suggest that the rise in the
incidence of an infectious disease itself, regardless of the availability of a vaccine to prevent
illness caused by that infectious disease, has the potential to positively influence parent's
attitudes and beliefs about other childhood vaccines.
The mechanism for this observed effect is unknown. However, given the strong
correlations between perceived likelihood of illness from or susceptibility to an infectious
disease and uptake of an available vaccine to protect against illness from that infectious
disease,1 it is possible that the SARS-CoV-2 pandemic increased parent perceptions of their
child's susceptibility to other infections for which there are available vaccines. Parents'
increased perceptions of the value of vaccines in preventing infectious disease could have
positively influenced parent attitudes toward those vaccines. Given vaccine attitudes are a
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strong predictor of intention to vaccinate,23 this explanation is aligned with the results of a
recent study in which investigators found, among parents surveyed at the start of the SARSCoV-2 pandemic, an increased intention to vaccinate their child against influenza.24
Second, our findings support the conclusion that any positive influence on parent
general attitudes about childhood vaccines from a rise in the incidence of an infectious
disease may be short-lived. Though attitudes about vaccines, like any attitude, are prone to
change over time,25 our findings are notable because the observed change occurred despite
the continued presence of SARS-CoV-2 and before the availability of a vaccine. Yet, there
are numerous social, personal, political, and cultural factors that influence vaccine attitudes,26
and our findings suggest these other factors can overcome the relative influence of the
infectious disease environment on those same attitudes. Indeed, it is possible that parents'
general vaccine attitudes were influenced in the lead up to the authorization of the first
SARS-CoV-2 vaccine by concerns that the authorization process was being politicized and
rushed.27
Our findings could be integrated into future public health campaigns in response to
outbreaks of emerging infectious diseases that have no available vaccine. For instance,
vaccination rates may decline during these outbreaks due to physical distancing
recommendations or parental concerns about exposure to the emerging infectious disease
during routine vaccination visits for their child, as occurred during the 2014-2016 Ebola
outbreak in Sierra Leone28 and in the SARS-CoV-2 pandemic in the US.29 A future public
health campaign could proactively harness the observed, albeit possibly short-lived, effect of
a reduction in negative parental attitudes about routine childhood vaccines after the onset of
an epidemic to blunt immediate declines in parent attendance at routine vaccination visits for
their child.
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This study is limited by its design. Natural experiments preclude randomization that
would ensure unmeasured confounders are equally distributed across populations. We did,
however, adjust for observed confounders and found no change in the significance of our
results. In addition, natural experiments are inherently confounded by secular trends.
However, finding no change in the proportion of parents responding negatively to a
concurrently assessed non-vaccine-related attitudinal item corroborates the interpretation that
the observed change in vaccine attitudes may be attributable to the onset of the pandemic.
Nonetheless, our results may be confounded by fewer parents with negative vaccine attitudes
completing the PACV-SF post-pandemic, fewer parents attending health supervision visits
post-pandemic, or other unobserved factors.
We also measured parent vaccine attitudes rather than actual vaccine behavior.
However, the instrument we used to measure parent vaccine attitudes is predictive of vaccine
behavior, 16-19 though it is unclear whether this correlation persists post-pandemic. We also
found no difference in the significance of our results when using the more restrictive PACVSF score threshold of ≥3 for negative vaccine attitudes that made misclassification of parents
as scoring ≥50 (out of 100) on the full PACV––the score threshold significantly associated
with vaccine behavior––less likely. Additional studies are needed to understand how, or
whether, the observed reduction in parent negative attitudes affected parent's vaccine
behavior.
Additional limitations include measurement of general vaccine attitudes in a crosssectional cohort which did not enable assessment of within-parent changes, as well as the
lack of measurement of potential mechanisms for the observed effect, such as changes in risk
perception. Our study sample was large and demographically representative of the
populations in Colorado and Washington State,30 enhancing the generalizability of our
results; however, our results may not be applicable to populations in other US states or other
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countries with demographics distinct from our study population. Similarly, the PACV was
initially validated in an English-speaking population from a specific US geographic location,
potentially limiting its validity for assessing parent attitudes about childhood vaccines in
other populations and geographic locations. However, more recent studies affirming the
validity of the PACV in other US geographic locations,19 among US Spanish-speaking
parents,14,31 and in other countries12,13,15 lessen this concern.

Conclusion
We observed a significant, though fleeting, effect of the SARS-CoV-2 pandemic on
parents' general attitudes about childhood vaccines. This effect could be proactively
harnessed to sustain or increase routine childhood vaccination during future outbreaks of
novel infectious diseases.
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Table 1. The short form of the Parent Attitudes about Childhood Vaccines (PACV-SF
or PACV-4).
Item
Have you ever delayed having your child get a
shot for reasons other than illness or allergy?
How concerned are you that a shot might not
prevent the disease?
Overall, how hesitant about childhood shots
would you consider yourself to be?
I trust the information I receive about shots.

Response Categories*
Yes/No/I don't know
Not at all concerned, Not too concerned, Not
sure, Somewhat concerned, Very concerned
Not at all hesitant, Not too hesitant, Not sure,
Somewhat hesitant, Very hesitant
Strongly agree, Agree, Not sure, Disagree,
Strongly disagree

*Responses in bold receive a score of 1; total scores for the PACV-SF range from 0-4
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Table 2. Demographic and Other Characteristics of Study Population.
No. (%)
Before Onset of
SARS-CoV-2
Pandemic
(n=1418)

After Onset of
SARS-CoV-2
Pandemic
(n=3144)

3933 (86.2)

1241 (87.5)

2692 (85.6)

0.05

3206 (72.2)

1000 (71.7)

2206 (72.5)

0.30

230 (5.2)

57 (4.1)

173 (5.7)

4204 (94.8)

1335 (95.9)

2869 (94.3)

503 (11.4)

146 (10.5)

357 (11.8)

3921 (88.6)

1242 (89.5)

2679 (88.2)

693 (16.0)
3643 (84.0)

204 (15.0)
1157 (85.0)

489 (16.4)
2486 (83.6)

0.70

499 (11.3)
16 (0.4)

140 (10.1)
7 (0.5)

359 (11.9)
9 (0.3)

0.06
0.22

3664 (85.3)
87 (2.0)
43 (1.0)
320 (7.5)
15 (0.3)
163 (3.8)

1152 (85.3)
22 (1.6)
14 (1.0)
108 (8.0)
7 (0.5)
47 (3.5)

2512 (85.4)
65 (2.2)
29 (1.0)
212 (7.2)
8 (0.3)
116 (3.9)

0.59

4201 (94.7)
234 (5.3)

1323 (94.8)
73 (5.2)

2878 (94.7)
161 (5.3)

0.90

2055 (46.4)

649 (46.8)

1406 (46.2)

0.34

Total
(n=4562)
Relationship to Child
Mother
Parent Age (years)*
≥30
Parent’s Marital Status*
Single, separated, widowed, or
divorced
Married or living with a partner
Parent Education*
High school graduate/GED or
less
Some college/2 year degree or
more
Household Income*
≤$50,000
>$50,000
Parent Ethnicity*
Hispanic/Latino
Completed Survey in Spanish
Parent Race*
White
Black/African American
American Indian/Alaska Native
Asian
Native Hawaiian/Pacific Islander
Multiracial
Number of Children in Household*
≤3
>3
Child Eligible for Survey is
First-Born*

P^

0.01

0.24

~

^

Comparison of populations before and after the onset of the pandemic using generalized estimating equations (GEE)
with binomial distribution, log link function and accounting for clustering at the clinic level
*
Numbers do not equal total N because of missing data
~
Reflects comparison of white vs. non-white populations before and after the onset of the pandemic
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